4: Statement of changes in beneficial ownership of securities
Published on October 27, 2003
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | ||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 10/24/2003 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
|||||||||||||||||||||||||
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 10/24/2003 | M | 3,000 | A | $17.35 | 14,490 | D | |||
| Common Stock | 10/24/2003 | M | 1,500 | A | $17.35 | 15,990 | D | |||
| Common Stock | 10/24/2003 | M | 4,710 | A | $19.25 | 20,700 | D | |||
| Common Stock | 10/24/2003 | M | 200 | A | $22.5 | 20,900 | D | |||
| Common Stock | 10/24/2003 | M | 5,826 | A | $15 | 26,726 | D | |||
| Common Stock | 10/24/2003 | M | 200 | A | $14.375 | 26,926 | D | |||
| Common Stock | 10/24/2003 | S | 15,436 | D | $47.0862 | 11,490(1) | D | |||
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Incentive Stock Option (right to buy) | $14.375 | 10/24/2003 | M | 200 | (2) | 12/15/2003 | Common Stock | 200 | $14.375 | 0 | D | ||||
| Incentive Stock Option (right to buy) | $15 | 10/24/2003 | M | 5,826 | (3) | 02/22/2004 | Common Stock | 5,826 | $15 | 0 | D | ||||
| Incentive Stock Option (right to buy) | $17.35 | 10/24/2003 | M | 1,500 | (4) | 02/13/2006 | Common Stock | 1,500 | $17.35 | 1,651 | D | ||||
| Incentive Stock Option (right to buy) | $17.35 | 10/24/2003 | M | 3,000 | (5) | 02/04/1997 | Common Stock | 3,000 | $17.35 | 0 | D | ||||
| Incentive Stock Option (right to buy) | $19.25 | 10/24/2003 | M | 4,710 | (6) | 02/08/2005 | Common Stock | 4,710 | $19.25 | 0 | D | ||||
| Incentive Stock Option (right to buy) | $22.5 | 10/24/2003 | M | 200 | (7) | 05/26/2005 | Common Stock | 200 | $22.5 | 0 | D | ||||
| Explanation of Responses: |
| 1. Reporting person also indirectly holds 5,046 shares of Common Stock of IDEXX Laboratories, Inc., which shares are held by the Andrew Q. Tonelli UTMA and Bret C. Tonelli UTMA. Reporting person disclaims beneficial ownership of these shares and this report should not be deemed an admission that the reporting person is the beneficial owner of such shares for purposes of Section 16 or any other purpose. |
| 2. Grant of option to buy shares of Common Stock exercisable in annual increments of 40 shares on the first anniversay of the date of grant (12/15/93). |
| 3. Grant of option to buy shares of Common Stock exercisable as to 664 shares on 2/22/95 and 2/22/96; 1,298 shares on 2/22/97 and 1,600 shares on 2/22/98 and 2/22/99. |
| 4. Grant of option to buy shares of Common Stock exercisable as to 1 share on 2/13/97 and 1,050 shares on 2/13/99, 2/13/00 and 2/13/01. |
| 5. Grant of option to buy shares of Common Stock exercisable as to 750 shares on 2/04/99, 2/04/00, 2/04/01 and 2/04/02. |
| 6. Grant of option to buy shares of Common Stock exercisable as to 710 shares on 2/08/98 and 2,000 shares on 2/08/99 and 2/08/00. |
| 7. Grant of option to buy shares of Common Stock exercisable as to 100 shares on 5/26/99 and 5/26/00. |
| Conan R. Deady, Attorney-in-Fact for Quentin J. Tonelli | 10/27/2003 | |
| ** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.